These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 943290)

  • 41. Vascular effects of apomorphine and related compounds in the perfused rat kidney.
    Schmidt M; Imbs JL; Neumeyer JL; Giesen EM; Schwartz J
    Eur J Pharmacol; 1984 Jan; 97(1-2):75-85. PubMed ID: 6141949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Aporphines. 39. Synthesis, dopamine receptor binding, and pharmacological activity of (R)-(-)- and (S)-(+)-2-hydroxyapomorphine.
    Neumeyer JL; Arana GW; Ram VJ; Kula NS; Baldessarini RJ
    J Med Chem; 1982 Aug; 25(8):990-2. PubMed ID: 7120288
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Aporphines. 34. (-)-2,10,11-Trihydroxy-N-n-propylnoraporphine, a novel dopaminergic aporphine alkaloid with anticonvulsant activity.
    Neumeyer JL; Law SJ; Meldrum B; Anlezark G; Watling KJ
    J Med Chem; 1981 Jul; 24(7):898-9. PubMed ID: 7277402
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Agonist-induced subsensitivity of adenylate cyclase coupled with a dopamine receptor in slices from rat corpus striatum.
    Memo M; Lovenberg W; Hanbauer I
    Proc Natl Acad Sci U S A; 1982 Jul; 79(14):4456-60. PubMed ID: 6956874
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional distinction between DA-stimulated adenylate cyclase and 3H-spiperone binding sites in rat striatum.
    Waddington JL; Cross AJ; Longden A; Owen F; Poulter M
    Eur J Pharmacol; 1979 Oct; 58(3):341-2. PubMed ID: 510367
    [No Abstract]   [Full Text] [Related]  

  • 46. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.
    Gnegy ME; Lucchelli A; Costa E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Dec; 301(2):121-7. PubMed ID: 202883
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central monoaminergic effects of two aporphine analogues to the putative serotonin-receptor agonist, 8-hydroxy-2-di-n-propylaminotetralin.
    Hjorth S; Neumeyer JL
    Neuropharmacology; 1984 Oct; 23(10):1187-90. PubMed ID: 6097834
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Haloperidol increases and apomorphine decreases striatal dopamine metabolism after destruction of striatal dopamine-sensitive adenylate cyclase by kainic acid.
    Di Chiara G; Porceddu ML; Spano PF; Gessa GL
    Brain Res; 1977 Jul; 130(2):374-82. PubMed ID: 884534
    [No Abstract]   [Full Text] [Related]  

  • 49. Aporphines. 30. (-)-N(2-chloroethyl)-10,11-dihydroxynor-aporphine (chloroethylnorapomorphine), a novel irreversible dopamine receptor antagonist.
    Neumeyer JL; Law SJ; Baldessarini RJ; Kula NS
    J Med Chem; 1980 Jun; 23(6):594-5. PubMed ID: 7392026
    [No Abstract]   [Full Text] [Related]  

  • 50. Interactions between lysergic acid diethylamide and dopamine-sensitive adenylate cyclase systems in rat brain.
    Hungen KV; Roberts S; Hill DF
    Brain Res; 1975 Aug; 94(1):57-66. PubMed ID: 238721
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chloroethylnorapomorphine, a proposed long-acting dopamine antagonist: interactions with dopamine receptors of mammalian forebrain in vitro.
    Baldessarini RJ; Kula NS; Arana GW; Neumeyer JL; Law SJ
    Eur J Pharmacol; 1980 Oct; 67(1):105-10. PubMed ID: 7418727
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Persistent increase in striatal dopamine stimulated adenylate cyclase activity persists for more than 6 months but disappears after 1 year following withdrawal from 18 months cis-flupenthixol intake.
    Murugaiah K; Fleminger S; Theodorou A; Jenner P; Marsden CD
    Biochem Pharmacol; 1983 Sep; 32(17):2495-9. PubMed ID: 6684429
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Pharmacological and biochemical characterization of dopamine receptors mediating stimulation of a high affinity GTPase in rat striatum.
    Onali P; Olianas MC
    Biochem Pharmacol; 1987 Sep; 36(17):2839-45. PubMed ID: 2820423
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of chronic lithium treatment on dopamine receptors in the rat corpus striatum. II. No effect on denervation or neuroleptic-induced supersensitivity.
    Staunton DA; Magistretti PJ; Shoemaker WJ; Deyo SN; Bloom FE
    Brain Res; 1982 Jan; 232(2):401-12. PubMed ID: 6322915
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Behavioral effects of apomorphine isomers in the rat: selective locomotor-inhibitory effects of S(+)N-n-propylnorapomorphine.
    Campbell A; Baldessarini RJ; Teicher MH; Neumeyer JL
    Psychopharmacology (Berl); 1986; 88(2):158-64. PubMed ID: 3081927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The effects of (-)N-(chloroethyl)-norapomorphine on [3H]-apomorphine binding to striatal dopamine receptors.
    Goosey MW; Doggett NS
    Biochem Pharmacol; 1982 Nov; 31(22):3693-4. PubMed ID: 7181954
    [No Abstract]   [Full Text] [Related]  

  • 57. Bromocriptine and hydergine: a comparison on striatal or hypothalamic adenylate cyclase activity.
    Portaleone P
    Pharmacology; 1978; 16 Suppl 1():207-9. PubMed ID: 643903
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Dissociation by the aporphine derivatives of the stereotypic and hyperactivity responses resulting from injections into the nucleus accumbens septi.
    Costall B; Naylor RJ; Neumeyer JL
    J Pharm Pharmacol; 1975 Nov; 27(11):875-7. PubMed ID: 1503
    [No Abstract]   [Full Text] [Related]  

  • 59. 2,3-Dihydroxy-9-amino-9,10-dihydrophenanthrene, a rigid congener of dopamine and isoapomorphine.
    Nichols DE; Toth JE; Kohli JD; Kotake CK
    J Med Chem; 1978 Apr; 21(4):395-8. PubMed ID: 650669
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Intranigral kainic acid: evidence for nigral non-dopaminergic neurons controlling posture and behavior in a manner opposite to the dopaminergic ones.
    Olianas MC; De Montis GM; Concu A; Tagliamonte A; di Chiara G
    Eur J Pharmacol; 1978 Jun; 49(3):223-32. PubMed ID: 566206
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.